{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:30:54Z","timestamp":1784068254832,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2023\/13279-5"],"award-info":[{"award-number":["2023\/13279-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["573747\/2008-3."],"award-info":[{"award-number":["573747\/2008-3."]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-04239-4","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:35:32Z","timestamp":1766795732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of cervical cancer and intrauterine device use: a narrative review"],"prefix":"10.1186","volume":"26","author":[{"given":"Christine M.","family":"Corr\u00eaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz C.","family":"Zeferino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassia T.","family":"Juliato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Bahamondes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"4239_CR1","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","volume":"366","author":"B Winner","year":"2012","unstructured":"Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998\u20132007.","journal-title":"N Engl J Med"},{"key":"4239_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/AOG.0b013e3181ec622b","volume":"116","author":"AM Kaunitz","year":"2010","unstructured":"Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, Muysers C, Jensen JT. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010;116:625\u201332.","journal-title":"Obstet Gynecol"},{"key":"4239_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.contraception.2004.12.026","volume":"72","author":"L Bahamondes","year":"2005","unstructured":"Bahamondes L, Faundes A, Lima BS, Lui-Filho JF, Pecci P, Matera S. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age. Contraception. 2005;72:337\u201341.","journal-title":"Contraception"},{"key":"4239_CR4","doi-asserted-by":"publisher","first-page":"e0147029","DOI":"10.1371\/journal.pone.0147029","volume":"11","author":"E Roura","year":"2016","unstructured":"Roura E, Travier N, Waterboer T, et al. The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort. PLoS One. 2016;11:e0147029.","journal-title":"PLoS One"},{"key":"4239_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Mu\u00f1oz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244\u201365.","journal-title":"J Clin Pathol"},{"key":"4239_CR6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1136\/bmj.318.7188.904","volume":"318","author":"M Quinn","year":"1999","unstructured":"Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in england: evaluation based on routinely collected statistics. BMJ. 1999;318:904\u20138.","journal-title":"BMJ"},{"key":"4239_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0002-9378(76)90569-X","volume":"125","author":"HF Sandmire","year":"1976","unstructured":"Sandmire HF, Austin SD, Bechtel RC. Carcinoma of the cervix in oral contraceptive steroid and IUD users and nonusers. Am J Obstet Gynecol. 1976;125:339\u201345.","journal-title":"Am J Obstet Gynecol"},{"key":"4239_CR8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(11)70223-6","volume":"12","author":"X Castellsagu\u00e9","year":"2011","unstructured":"Castellsagu\u00e9 X, D\u00edaz M, Vaccarella S, et al. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies. Lancet Oncol. 2011;12:1023\u201331.","journal-title":"Lancet Oncol"},{"key":"4239_CR9","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1097\/AOG.0000000000002307","volume":"130","author":"VK Cortessis","year":"2017","unstructured":"Cortessis VK, Barrett M, Brown Wade N, et al. Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis. Obstet Gynecol. 2017;130:1226\u201336.","journal-title":"Obstet Gynecol"},{"key":"4239_CR10","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1093\/humrep\/deab066","volume":"36","author":"M Skorstengaard","year":"2021","unstructured":"Skorstengaard M, Lynge E, Napolitano G, Blaak\u00e6r J, Bor P. Risk of precancerous cervical lesions in women using a hormone-containing intrauterine device and other contraceptives: a register-based cohort study from Denmark. Hum Reprod. 2021;36:1796\u2013807.","journal-title":"Hum Reprod"},{"key":"4239_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/AOG.0000000000003656","volume":"135","author":"ME Spotnitz","year":"2020","unstructured":"Spotnitz ME, Natarajan K, Ryan PB, Westhoff CL. Relative risk of cervical neoplasms among copper and levonorgestrel-releasing intrauterine system users. Obstet Gynecol. 2020;135:319\u201327.","journal-title":"Obstet Gynecol"},{"key":"4239_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejca.2019.10.009","volume":"124","author":"DL Loopik","year":"2020","unstructured":"Loopik DL, IntHout J, Melchers WJG, Massuger LFAG, Bekkers RLM, Siebers AG. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study. Eur J Cancer. 2020;124:102\u20139.","journal-title":"Eur J Cancer"},{"key":"4239_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA\u2010P) 2015 statement. Syst Rev. 2015;4:1\u20139.","journal-title":"Syst Rev"},{"key":"4239_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/humupd\/dmh058","volume":"11","author":"JA Collins","year":"2005","unstructured":"Collins JA, Fauser BC. Balancing the strengths of systematic and narrative reviews. Hum Reprod Update. 2005;11:103\u20134.","journal-title":"Hum Reprod Update"},{"key":"4239_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1179\/2047480615Z.000000000329","volume":"24","author":"R Ferrari","year":"2015","unstructured":"Ferrari R. Writing narrative style literature reviews. Med Writ. 2015;24:230\u20135.","journal-title":"Med Writ"},{"key":"4239_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ije\/19.1.4","volume":"19","author":"LA Brinton","year":"1990","unstructured":"Brinton LA, Reeves WC, Brenes MM, et al. Oral contraceptive use and risk of invasive cervical cancer. Int J Epidemiol. 1990;19:4\u201311.","journal-title":"Int J Epidemiol"},{"key":"4239_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1089\/152460900318498","volume":"9","author":"HQ Li","year":"2000","unstructured":"Li HQ, Thomas DB, Jin SK, Wu F. Tubal sterilization and use of an IUD and risk of cervical cancer. J Womens Health Gend Based Med. 2000;9:303\u201310.","journal-title":"J Womens Health Gend Based Med"},{"key":"4239_CR18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/ijc.20600","volume":"113","author":"D Hammouda","year":"2005","unstructured":"Hammouda D, Mu\u00f1oz N, Herrero R, et al. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer. 2005;113:483\u20139.","journal-title":"Int J Cancer"},{"key":"4239_CR19","doi-asserted-by":"crossref","unstructured":"Yi H, Zhang N, Huang J et al. Association of levonorgestrel-releasing intrauterine device with gynecologic and breast cancers: a national cohort study in Sweden. Am J Obstet Gynecol. 2024;231:450.e1-450.e12.","DOI":"10.1016\/j.ajog.2024.05.011"},{"key":"4239_CR20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/oxfordjournals.aje.a114699","volume":"126","author":"DD Celentano","year":"1987","unstructured":"Celentano DD, Klassen AC, Weisman CS, Rosenshein NB. The role of contraceptive use in cervical cancer: the Maryland cervical cancer case-control study. Am J Epidemiol. 1987;126:592\u2013604.","journal-title":"Am J Epidemiol"},{"key":"4239_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/ije\/20.4.865","volume":"20","author":"DL Lassise","year":"1991","unstructured":"Lassise DL, Savitz DA, Hamman RF, Bar\u00f3n AE, Brinton LA, Levines RS. Invasive cervical cancer and intrauterine device use. Int J Epidemiol. 1991;20:865\u201370.","journal-title":"Int J Epidemiol"},{"key":"4239_CR22","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/ije\/21.5.1030","volume":"21","author":"F Parazzini","year":"1992","unstructured":"Parazzini F, La Vecchia C, Negri E. Use of intrauterine device and risk of invasive cervical cancer. Int J Epidemiol. 1992;21:1030\u20131.","journal-title":"Int J Epidemiol"},{"key":"4239_CR23","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/ije\/23.5.906","volume":"23","author":"MA Williams","year":"1994","unstructured":"Williams MA, Kenya PR, Mati JK, Thomas DB. Risk factors for invasive cervical cancer in Kenyan women. Int J Epidemiol. 1994;23:906\u201312.","journal-title":"Int J Epidemiol"},{"issue":"18","key":"4239_CR24","first-page":"30144","volume":"S0010-7824","author":"S Averbach","year":"2018","unstructured":"Averbach S, Silverberg MJ, Leyden W, Smith-McCune K, Raine-Bennett T, Sawaya GF. Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer. Contraception. 2018;S0010-7824(18):30144\u20136.","journal-title":"Contraception"},{"key":"4239_CR25","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/ije\/29.6.983","volume":"29","author":"M Schiff","year":"2000","unstructured":"Schiff M, Miller J, Masuk M, et al. Contraceptive and reproductive risk factors for cervical intraepithelial neoplasia in American Indian women. Int J Epidemiol. 2000;29:983\u201390.","journal-title":"Int J Epidemiol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-04239-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04239-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04239-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:38:55Z","timestamp":1769603935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-025-04239-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4239"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-04239-4","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LB was a member of some boards and received honorarium as speaker from Organon and Bayer. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}